BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Which Countries Would Suffer Most in a Global Energy Shutdown? This Study Has Answers - 2US healthcare spending soars to over $5 trillion in 2024
- 3Figure out How to Recognize Early Indications of Depressions
- 4Instructions to Upgrade the Mechanical Highlights of Your Shrewd Bed for a Superior Night's Rest
- 5Deadly attack on kindergarten reported in Sudan
- Outside Lovers' Decision: Favored Climbing Rucksacks
- 2 ways you can conserve the water used to make your food
- How is 'A Knight of the Seven Kingdoms' connected to 'Game of Thrones'?
- A red meat allergy from tick bites is spreading – and the lone star tick isn’t the only alpha-gal carrier to worry about
- Two die and thousands homeless after flooding hits Russia's Dagestan
- Why home maintenance deserves a spot in the annual health and budget plans
- Extraordinary Guinness World Records That Will Astound You
- Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand.
- Warning for snow and ice extended
